Format

Send to

Choose Destination
Hepatology. 2014 Aug;60(2):458-60. doi: 10.1002/hep.27061. Epub 2014 Jun 26.

Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases.

Author information

1
Vascular Biology Laboratory, AU-KBC Research Center, Chennai, India; Center for Biotechnology, Anna University, Chennai, India.
PMID:
24504762
DOI:
10.1002/hep.27061
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center